258 related articles for article (PubMed ID: 19172358)
1. The evolution of tuberculosis virulence.
Basu S; Galvani AP
Bull Math Biol; 2009 Jul; 71(5):1073-88. PubMed ID: 19172358
[TBL] [Abstract][Full Text] [Related]
2. Ancestral Mycobacterium tuberculosis genotypes in India: implications for TB control programmes.
Ahmed N; Ehtesham NZ; Hasnain SE
Infect Genet Evol; 2009 Jan; 9(1):142-6. PubMed ID: 18992848
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity in the tubercle bacillus: molecular and evolutionary determinants.
Gordon SV; Bottai D; Simeone R; Stinear TP; Brosch R
Bioessays; 2009 Apr; 31(4):378-88. PubMed ID: 19274661
[TBL] [Abstract][Full Text] [Related]
4. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance.
Lipsitch M; Levin BR
Int J Tuberc Lung Dis; 1998 Mar; 2(3):187-99. PubMed ID: 9526190
[TBL] [Abstract][Full Text] [Related]
5. Lessons from molecular epidemiology and comparative genomics.
Mathema B; Kurepina N; Fallows D; Kreiswirth BN
Semin Respir Crit Care Med; 2008 Oct; 29(5):467-80. PubMed ID: 18810681
[TBL] [Abstract][Full Text] [Related]
6. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis.
Palomino JC
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):103-11. PubMed ID: 19416361
[TBL] [Abstract][Full Text] [Related]
7. Molecular, epidemiological and infectivity characterisation of a Mycobacterium tuberculosis strain prevalent in Madrid.
Martín A; Chaves F; Iñigo J; Alonso M; Sola C; Rastogi N; Ruiz Serrano MJ; Palenque E; Bouza E; García de Viedma D
Clin Microbiol Infect; 2007 Dec; 13(12):1210-3. PubMed ID: 17825090
[TBL] [Abstract][Full Text] [Related]
8. The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics.
Basu S; Orenstein E; Galvani AP
J Infect Dis; 2008 Nov; 198(10):1502-13. PubMed ID: 18816192
[TBL] [Abstract][Full Text] [Related]
9. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
[TBL] [Abstract][Full Text] [Related]
10. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance.
Blower SM; Chou T
Nat Med; 2004 Oct; 10(10):1111-6. PubMed ID: 15378053
[TBL] [Abstract][Full Text] [Related]
11. Within-host evolution and virulence in microparasites.
André JB; Godelle B
J Theor Biol; 2006 Jul; 241(2):402-9. PubMed ID: 16442566
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
[TBL] [Abstract][Full Text] [Related]
13. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
Chen JM; Islam ST; Ren H; Liu J
Vaccine; 2007 Nov; 25(48):8114-22. PubMed ID: 17954004
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis: evolution in millennia and minutes.
Gillespie SH
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1317-20. PubMed ID: 17956341
[TBL] [Abstract][Full Text] [Related]
15. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
[TBL] [Abstract][Full Text] [Related]
16. Horizontal transfer of a virulence operon to the ancestor of Mycobacterium tuberculosis.
Rosas-Magallanes V; Deschavanne P; Quintana-Murci L; Brosch R; Gicquel B; Neyrolles O
Mol Biol Evol; 2006 Jun; 23(6):1129-35. PubMed ID: 16520338
[TBL] [Abstract][Full Text] [Related]
17. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
Shenai S; Rodrigues C; Sadani M; Sukhadia N; Mehta A
Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
[TBL] [Abstract][Full Text] [Related]
18. The effect of elevated mutation rates on the evolution of cooperation and virulence of Pseudomonas aeruginosa.
Racey D; Inglis RF; Harrison F; Oliver A; Buckling A
Evolution; 2010 Feb; 64(2):515-21. PubMed ID: 19686265
[TBL] [Abstract][Full Text] [Related]
19. The role of IS6110 in the evolution of Mycobacterium tuberculosis.
McEvoy CR; Falmer AA; Gey van Pittius NC; Victor TC; van Helden PD; Warren RM
Tuberculosis (Edinb); 2007 Sep; 87(5):393-404. PubMed ID: 17627889
[TBL] [Abstract][Full Text] [Related]
20. New genetic approaches shed light on TB virulence.
Murry JP; Rubin EJ
Trends Microbiol; 2005 Aug; 13(8):366-72. PubMed ID: 15982889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
